The last three decades have seen dramatic advances in the use of immunotherapies to treat cancer, primarily in the form of monoclonal antibodies targeting cancer cells directly or recruiting the immune system against them. More recently, immune cells themselves are being used as anticancer treatments, led by chimeric antigen receptor…
The New England Journal of Medicine: Search Results in Hematology/Oncology
